Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7MSZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,858
Award facts
- Contract value 100% obligated
- $15,858.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,858 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Wegovy 2.4 mg/0.75 mL pen injections. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract is not set-aside and was competitively awarded. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of December 9, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System. The company's comprehensive IDC vehicle enables it to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. This specific delivery order for Wegovy, a GLP-1 receptor agonist used in diabetes and weight management treatment, demonstrates AmerisourceBergen's capability to fulfill urgent federal pharmaceutical needs through its established relationship with DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7MSZ?
SPE2DR26F7MSZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F7MSZ worth?
The government has obligated $15,858 on SPE2DR26F7MSZ.
Is contract SPE2DR26F7MSZ an order under another contract?
Yes. SPE2DR26F7MSZ is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MSZ competed?
The extent of competition for SPE2DR26F7MSZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award